Literature DB >> 24866232

The impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens.

Raymond U Osarogiagbon1, Ransome Eke2, Srishti Sareen3, Cynthia Leary4, LaShundra Coleman3, Nicholas Faris3, Xinhua Yu2, David Spencer4.   

Abstract

Although thorough pathologic nodal staging provides the greatest prognostic information in patients with potentially curable non-small cell lung cancer, N1 nodal metastasis is frequently missed. We tested the impact of corrective intervention with a novel pathology gross dissection protocol on intrapulmonary lymph node retrieval. This study is a retrospective review of consecutive lobectomy, or greater, lung resection specimens over a period of 15 months before and 15 months after training pathologist's assistants on the novel dissection protocol. One hundred forty one specimens were examined before and 121 specimens after introduction of the novel dissection protocol. The median number of intrapulmonary lymph nodes retrieved increased from 2 to 5 (P<.0001), and the 75th to 100th percentile range of detected intrapulmonary lymph node metastasis increased from 0 to 5 to 0 to 17 (P=.0003). In multivariate analysis, the extent of resection, examination period (preintervention or postintervention), and pathologic N1 (vs N0) status were most strongly associated with a higher number of intrapulmonary lymph nodes examined. A novel pathology dissection protocol is a feasible and effective means of improving the retrieval of intrapulmonary lymph nodes for examination. Further studies to enhance dissemination and implementation of this novel pathology dissection protocol are warranted.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Non–small cell lung cancer; Pathologic nodal staging; Quality improvement

Mesh:

Year:  2014        PMID: 24866232      PMCID: PMC4099318          DOI: 10.1016/j.anndiagpath.2014.03.005

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  31 in total

1.  Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancer.

Authors:  Raymond U Osarogiagbon; Laura E Miller; Robert A Ramirez; Christopher G Wang; Thomas F O'Brien; Xinhua Yu; Alim Khandekar; Glenn P Schoettle; Samuel G Robbins; Edward T Robbins; Jeffrey B Gibson
Journal:  J Thorac Oncol       Date:  2012-08       Impact factor: 15.609

2.  Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer.

Authors:  Robert A Ramirez; Christopher G Wang; Laura E Miller; Courtney A Adair; Allen Berry; Xinhua Yu; Thomas F O'Brien; Raymond U Osarogiagbon
Journal:  J Clin Oncol       Date:  2012-07-09       Impact factor: 44.544

3.  A new device for the identification of lymph nodes at lung cancer surgery.

Authors:  Thomas F Molnar
Journal:  Eur J Cardiothorac Surg       Date:  2006-12-21       Impact factor: 4.191

4.  Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.

Authors:  Raymond U Osarogiagbon; Xinhua Yu
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

5.  Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?

Authors:  Shenhai Wei; Hisao Asamura; Riken Kawachi; Hiroyuki Sakurai; Shun-ichi Watanabe
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

6.  Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Authors:  Michelle S Ludwig; Michael Goodman; Daniel L Miller; Peter A S Johnstone
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

7.  Surgical specimen identification errors: a new measure of quality in surgical care.

Authors:  Martin A Makary; Jonathan Epstein; Peter J Pronovost; E Anne Millman; Emily C Hartmann; Julie A Freischlag
Journal:  Surgery       Date:  2007-01-24       Impact factor: 3.982

8.  Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients.

Authors:  Joachim Pfannschmidt; Thomas Muley; Heinrich Bülzebruck; Hans Hoffmann; Hendrik Dienemann
Journal:  Lung Cancer       Date:  2006-11-22       Impact factor: 5.705

9.  Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Xinhua Yu
Journal:  Ann Thorac Surg       Date:  2013-07-30       Impact factor: 4.330

10.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

View more
  11 in total

1.  Perspective and clinical relevance of intrapulmonary lymph node retrieval: response to the editorial by Tantraworasin and colleagues and the editorial by Marc Riquet and colleagues.

Authors:  Nan Wu; Xing Wang; Yaqi Wang; Shi Yan
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

2.  Role of intrapulmonary lymph node retrieval for pathological examination in resectable non-small cell lung cancer.

Authors:  Apichat Tantraworasin; Emanuela Taioli; Sophon Siwachat; Somcharoen Saeteng
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.

Authors:  Meredith A Ray; Nicholas R Faris; Matthew P Smeltzer; Carrie Fehnel; Cheryl Houston-Harris; Paul Levy; Lynn Wiggins; Vishal Sachdev; Todd Robbins; David Spencer; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2018-03-11       Impact factor: 4.330

4.  Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort.

Authors:  Nicholas R Faris; Matthew P Smeltzer; Fujin Lu; Carrie L Fehnel; Nibedita Chakraborty; Cheryl L Houston-Harris; E Todd Robbins; Raymond S Signore; Laura M McHugh; Bradley A Wolf; Lynn Wiggins; Paul Levy; Vishal Sachdev; Raymond U Osarogiagbon
Journal:  Semin Thorac Cardiovasc Surg       Date:  2016-10-14

5.  Improving the pathologic evaluation of lung cancer resection specimens.

Authors:  Raymond U Osarogiagbon; Holly L Hilsenbeck; Elizabeth W Sales; Allen Berry; Robert W Jarrett; Christopher S Giampapa; Clara N Finch-Cruz; David Spencer
Journal:  Transl Lung Cancer Res       Date:  2015-08

6.  Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non-Small Cell Lung Cancer.

Authors:  Matthew P Smeltzer; Nicholas Faris; Xinhua Yu; Robert A Ramirez; Laura E M Ramirez; Christopher G Wang; Courtney Adair; Allen Berry; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2016-06-03       Impact factor: 4.330

7.  Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).

Authors:  Raymond U Osarogiagbon; Paul A Decker; Karla Ballman; Dennis Wigle; Mark S Allen; Gail E Darling
Journal:  Ann Thorac Surg       Date:  2016-06-02       Impact factor: 4.330

8.  Survival Before and After Direct Surgical Quality Feedback in a Population-Based Lung Cancer Cohort.

Authors:  Matthew P Smeltzer; Nicholas R Faris; Meredith A Ray; Carrie Fehnel; Cheryl Houston-Harris; Philip Ojeabulu; Olawale Akinbobola; Yu-Sheng Lee; Meghan Meadows; R Samuel Signore; Lynn Wiggins; David Talton; Edmond Owen; Lawrence E Deese; Richard Eubanks; Bradley A Wolf; Paul Levy; E Todd Robbins; Raymond U Osarogiagbon
Journal:  Ann Thorac Surg       Date:  2018-12-27       Impact factor: 4.330

9.  Survival After Mediastinal Node Dissection, Systematic Sampling, or Neither for Early Stage NSCLC.

Authors:  Meredith A Ray; Matthew P Smeltzer; Nicholas R Faris; Raymond U Osarogiagbon
Journal:  J Thorac Oncol       Date:  2020-06-20       Impact factor: 15.609

10.  Skip metastasis in mediastinal lymph node is a favorable prognostic factor in N2 lung cancer patients: a meta-analysis.

Authors:  Zihuai Wang; Jiahan Cheng; Wenyu Huang; Diou Cheng; Yilin Liu; Qiang Pu; Nathan E Reticker-Flynn; Lunxu Liu
Journal:  Ann Transl Med       Date:  2021-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.